Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report.

Nafis Shafizadeh, Sanjay Kakar, Hepatocellular Carcinoma: Histologic Subtypes. Surgical Pathology Clinics. ,vol. 6, pp. 367- 384 ,(2013) , 10.1016/J.PATH.2013.03.007

CHUN-CHAO ZHU, MAO-RAN LI, TIAN-LONG LIN, GANG ZHAO, Sarcomatoid carcinoma of the stomach: A case report and literature review Oncology Letters. ,vol. 10, pp. 1385- 1389 ,(2015) , 10.3892/OL.2015.3460

Naoki Yoshida, Yutaka Midorikawa, Takahiro Kajiwara, Nao Yoshida, Hisashi Nakayama, Masahiko Sugitani, Tadatoshi Takayama, Hepatocellular Carcinoma with Sarcomatoid Change without Anticancer Therapies Case Reports in Gastroenterology. ,vol. 7, pp. 169- 174 ,(2013) , 10.1159/000350558

Min-Sun Cho, Shi Nae Lee, Sun Hee Sung, Woon Sup Han, Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult Pathology International. ,vol. 54, pp. 446- 450 ,(2004) , 10.1111/J.1440-1827.2004.01640.X

Anthony B El-Khoueiry, Bruno Sangro, Thomas Yau, Todd S Crocenzi, Masatoshi Kudo, Chiun Hsu, Tae-You Kim, Su-Pin Choo, Jörg Trojan, Theodore H Welling, Tim Meyer, Yoon-Koo Kang, Winnie Yeo, Akhil Chopra, Jeffrey Anderson, Christine dela Cruz, Lixin Lang, Jaclyn Neely, Hao Tang, Homa B Dastani, Ignacio Melero, Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial The Lancet. ,vol. 389, pp. 2492- 2502 ,(2017) , 10.1016/S0140-6736(17)31046-2

Michael S. Torbenson, Morphologic Subtypes of Hepatocellular Carcinoma Gastroenterology Clinics of North America. ,vol. 46, pp. 365- 391 ,(2017) , 10.1016/J.GTC.2017.01.009

Qianru Gu, Xia Yu, Hanbin Chen, Guorong Chen, Clinicopathological features of combined hepatocellular-cholangiocarcinoma with sarcomatous change: Case report and literature review. Medicine. ,vol. 97, ,(2018) , 10.1097/MD.0000000000009640

J. Fuentes-Antrás, M. Provencio, E. Díaz-Rubio, Hyperprogression as a distinct outcome after immunotherapy. Cancer Treatment Reviews. ,vol. 70, pp. 16- 21 ,(2018) , 10.1016/J.CTRV.2018.07.006

Sih-Han Liao, Tung-Hung Su, Yung-Ming Jeng, Po-Chin Liang, Ding-Shinn Chen, Chien-Hung Chen, Jia-Horng Kao, Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma Hepatology. ,vol. 69, pp. 209- 221 ,(2019) , 10.1002/HEP.30162

Stéphane Champiat, Roberto Ferrara, Christophe Massard, Benjamin Besse, Aurélien Marabelle, Jean-Charles Soria, Charles Ferté, Hyperprogressive disease: recognizing a novel pattern to improve patient management Nature Reviews Clinical Oncology. ,vol. 15, pp. 748- 762 ,(2018) , 10.1038/S41571-018-0111-2